Benicar Related Clinical Trials
Olmesartan in Essential Hypertension [Completed]
An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension [Completed]
Fed Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg [Completed]
Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg [Completed]
Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension [Completed]
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure [Active, not recruiting]
The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE) [Completed]
A Study to Evaluate the Efficacy and Safety of TAK-491 in Subjects With Essential Hypertension [Active, not recruiting]
Parallel-Group Comparison of Olmesartan, Amlodipine and Hydrochlorothiazide in Hypertension [Recruiting]
Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Recruiting]
Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Recruiting]
Olmesartan Medoxomil and Diabetic Nephropathy [Completed]
Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome [Recruiting]
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension [Completed]
Safety and Tolerability of TAK-491 Plus Chlorthalidone Compared to Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Essential Hypertension [Not yet recruiting]
An Efficacy and Safety Study of TAK-491 Compared to Valsartan and Olmesartan in Subjects With Essential Hypertension. [Recruiting]
Olmesartan Medoxomil in Atherosclerosis [Completed]
VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [Completed]
Hydrochlorothiazide as Add-on to Olmesartan/Amlodipine in Hypertension [Recruiting]
Olmesartan Pediatric Pharmacokinetic (PK) Study [Completed]
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension [Active, not recruiting]
An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes [Completed]
A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension [Completed]
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial [Active, not recruiting]
The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects [Completed]
Efficacy and Safety of TAK-491CLD in Subjects With Moderate to Severe Hypertension [Recruiting]
Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection [Recruiting]
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension [Active, not recruiting]
A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin [Completed]
Olmesartan Comparison to Losartan in Hypertensive Subjects [Recruiting]
Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension [Active, not recruiting]
Amlodipine as Add-on to Olmesartan in Hypertension [Completed]
A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis [Completed]
Study to Demonstrate the Non-Inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-Type (or Brain) Natriuretic Peptide Levels at Week 24 [Recruiting]
Olmesartan Medoxomil in Hypertension and Renal Impairment [Completed]
Study to Evaluate After 18 Weeks of Treatment, the Safety and Effectiveness of Combined Treatment With Olmesartan Medoxomil and Amlodipine Alone, and With Hydrocholorothiazide, to Reduce High Blood Pressure in Type 2 Diabetic Subjects [Recruiting]
Olmesartan as an Add-on to Amlodipine in Hypertension [Completed]
Olmesartan on Ambulatory Blood Pressure Change [Not yet recruiting]
Study of co-Administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension [Completed]
Supplemental Benefit of Angiotensin Receptor Blocker (ARB) in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT Trial) [Recruiting]
Olmesartan Medoxomil in Diabetes Mellitus [Active, not recruiting]
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension [Recruiting]
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker [Completed]
Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) [Recruiting]
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure [Recruiting]
Renin Profiling in Selection of Initial Antihypertensive Drug [Recruiting]
OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study [Active, not recruiting]
Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation [Completed]
Efficacy and Safety of Valsartan and Amlodipine in Adults With Moderate, Inadequately Controlled Hypertension [Active, not recruiting]
Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance [Recruiting]
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment [Recruiting]
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension [Completed]
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy [Active, not recruiting]
|
